血清α—L一岩藻糖甙酶含量诊断原发性肝癌有关问题的评价
The evaluation of the content of α-L-fucosidase of serum to diagnose the primary liver cancer
-
摘要: 本文对原发性肝癌354例、转移性肝癌123例、肝血管瘤38例、肝囊肿32例、肝硬化52例、慢性乙肝202例、正常人对照106例，共计907例进行了血清a—L一岩藻糖甙酶（AFU）的测定，其敏感性、特异性、阳性预报率与阴性预报率准确度分别89.8％、93.1％、89.3％、93.5％、91.8％。AFU活性与甲胎蛋白（AFP）浓度间均无明显相关性。AFU与AFP联合检测对原发性肝癌的诊断阳性率达94.6％Abstract: At this study,we detect the content of a-L-fucosidase (AFU) of serum,conclude354 cases of primary liver cancer. 123 cases of metastatic liver cancer. 38 cases of liverhemangioma. 32 cases of liver cystis. 52 cases of liver cirrhosis. 202 cases of chronic hepatitis B and 106 cases of normal control, there are 907 cases altogether,the sensitivity.specificity. positive forecast rate and negative forecast rate is 89.8%. 93.1 %. 89.3%.93.5 %. 91.8 % respectively,there has no relativity between the activity of AFU and theconcentration of a - feta - protein (AFP). the diagnosis rate have been up to 94.6%when we detect both the AFU and AFP.
-
Key words:
- α-L-fucosidase /
- primary liver cancer /
- α-feta-protein
-
-
1. 相甲梅, 等. 肝脏占位性病变患者血清。α-L-岩藻糖贰酶活性测定及其临床意义. 中华医学检验杂志, 190, 13(1) 2. 左国庆, 等. 血清α-L-岩藻搪贰酶对原发性肝癌诊断价值的进-步探讨. 临床肝胆病杂志, 191, 7(3):124 3. 于志伟, 等, 血清α-L-岩藻糖贰酶的测定方法. 中华医学检验杂志, 1992, 15(3):139 4. 王国祯, 等. 血清α-L-岩藻糖贰酶, GGT同I酶Ⅱ, α1-抗胰蛋白酶对原发性肝癌的诊断价值. 中华消化杂志, 1989, 9(1):54 5. 相甲梅, 等. 血清α1-L-岩藻糖贰酶对原发性肝瘤的诊断价值. 中华消化杂志, 1989, 9(2):92 6. 徐萍, 等. 消化系肿瘤、肝硬化及胚胎组织中。α1-L-岩藻糖贰酶的研究. 中华消化杂志, 1990, 10(3):181 7. 许志金, 等. 原发性肝癌血清AFP与AFU联合检测的评价. 实用医学检验杂志, 1995, 2(3):52
计量
- 文章访问数: 987
- HTML全文浏览量: 25
- PDF下载量: 186
下载:
